{"author": "Abdel-Razeq, H ", "adress": "Univ Jordan, King Hussein Canc Ctr, Sect Hematol & Med Oncol, Sch Med,Dept Internal Me, POB 1269, Amman 11941, Jordan", "emails": ["habdelrazeq@khcc.jo"], "title": "Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients"}